Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Joint agreement for TRK-820 in Japan

March 21, 2005

Psoraxine phase II study fails to meet primary endpoint

March 21, 2005

Basilea advances compound with potential for acne and rosacea

March 16, 2005

FDA issues public health advisory for Elidel and Protopic

March 11, 2005

Galderma discloses new PPARgamma receptor agonists

March 10, 2005

New Melanotan trials cleared to begin in Australia and Finland

March 10, 2005

Topical compound containing MMP and PKC inhibitors improves skin hypersensitivity in humans

March 4, 2005

S-236 cream effective in pruritis, xerosis and atopic dermatitis in humans

March 4, 2005

New phase II study to test TB4 for epidermolysis bullosa

March 4, 2005

Norpiperidine imidazoazepines: a novel class of selective nonsedative H1 antihistamines

March 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...